TY - JOUR
T1 - Lesch-nyhan syndrome
T2 - CSF neurotransmitter abnormalities
AU - Silverstein, Faye S.
AU - Johnston, Michael V.
AU - Hutchinson, Raymond J.
AU - Edwards, N. Lawrence
PY - 1985/6
Y1 - 1985/6
N2 - Serial determinations of spinal fluid homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were made in four patients with the Lesch-Nyhan syndrome over a 5-year period. Control spinal fluids for age-matched comparison were obtained from 194 neurologic and nonneurologic pediatric patients. A rapid decline in control spinal fluid HVA and 5-HIAA occurs over the first 3 years of life (50 and 60%, respectively), and a more gradual decline persists throughout adolescence. The Lesch-Nyhan subjects have similar age-related changes in their spinal fluid neurotransmitter levels. Sequential 5-HIAA determinations from the four Lesch-Nyhan boys fall within the control range. The Lesch-Nyhan HVA levels are lower than the mean value for the age-matched control group in 18 of 19 samples. Ten of 19 determinations fell below the control range. Our findings provide evidence for altered CNS dopamine metabolism in the Lesch-Nyhan syndrome.
AB - Serial determinations of spinal fluid homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were made in four patients with the Lesch-Nyhan syndrome over a 5-year period. Control spinal fluids for age-matched comparison were obtained from 194 neurologic and nonneurologic pediatric patients. A rapid decline in control spinal fluid HVA and 5-HIAA occurs over the first 3 years of life (50 and 60%, respectively), and a more gradual decline persists throughout adolescence. The Lesch-Nyhan subjects have similar age-related changes in their spinal fluid neurotransmitter levels. Sequential 5-HIAA determinations from the four Lesch-Nyhan boys fall within the control range. The Lesch-Nyhan HVA levels are lower than the mean value for the age-matched control group in 18 of 19 samples. Ten of 19 determinations fell below the control range. Our findings provide evidence for altered CNS dopamine metabolism in the Lesch-Nyhan syndrome.
UR - http://www.scopus.com/inward/record.url?scp=0021883954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021883954&partnerID=8YFLogxK
U2 - 10.1212/wnl.35.6.907
DO - 10.1212/wnl.35.6.907
M3 - Article
C2 - 2582310
AN - SCOPUS:0021883954
SN - 0028-3878
VL - 35
SP - 907
EP - 911
JO - Neurology
JF - Neurology
IS - 6
ER -